Citations (161)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Joshua T. Ellsworth. (2022) Spice, vulnerability, and victimization: Synthetic cannabinoids and interpersonal crime victimization among homeless adults. Substance Abuse 43:1, pages 32-38.
Read now
Read now
Mary Alexandra Schleiff, Deepika Dhaware & Jasleen K. Sodhi. (2021) Recent advances in computational metabolite structure predictions and altered metabolic pathways assessment to inform drug development processes. Drug Metabolism Reviews 53:2, pages 173-187.
Read now
Read now
Sabrina Jones, Azure L. Yarbrough, Amal Shoeib, John M. Bush, William E. Fantegrossi, Paul L. Prather, Anna Radominska-Pandya & Ryoichi Fujiwara. (2019) Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22). Xenobiotica 49:12, pages 1388-1395.
Read now
Read now
Amelia M. Kasper, Alison D. Ridpath, Roy R. Gerona, Robert Cox, Robert Galli, Patrick B. Kyle, Christina Parker, Justin K. Arnold, Kevin Chatham-Stephens, Melissa A. Morrison, Olaniyi Olayinka, Nykiconia Preacely, Stephanie M. Kieszak, Colleen Martin, Joshua G. Schier, Amy Wolkin, Paul Byers & Thomas Dobbs. (2019) Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015). Clinical Toxicology 57:1, pages 10-18.
Read now
Read now
Ali A El-Solh. (2018) Management of nightmares in patients with posttraumatic stress disorder: current perspectives. Nature and Science of Sleep 10, pages 409-420.
Read now
Read now
Faith A. Ihongbe, Timothy O. Ihongbe, Saba W. Masho & Katerina Petrov. (2018) Association between synthetic cannabinoid use and depressive symptomology: Analysis of a US national survey of high-school seniors. Journal of Substance Use 23:2, pages 113-119.
Read now
Read now
Rex Pui Kin Lam, Magdalene Huen Yin Tang, Siu Chung Leung, Yeow Kuan Chong, Matthew Sik Hon Tsui & Tony Wing Lai Mak. (2017) Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations. Clinical Toxicology 55:7, pages 662-667.
Read now
Read now
Juliana Tournebize, Valérie Gibaja & Jean-Pierre Kahn. (2017) Acute effects of synthetic cannabinoids: Update 2015. Substance Abuse 38:3, pages 344-366.
Read now
Read now
Kathleen L. Egan, Jennifer Toller Erausquin, Jeffrey J. Milroy & David L. Wyrick. (2016) Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes. Journal of Psychoactive Drugs 48:3, pages 166-172.
Read now
Read now
Robert J. Tait, David Caldicott, David Mountain, Simon L. Hill & Simon Lenton. (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology 54:1, pages 1-13.
Read now
Read now
Danièle Debruyne & Reynald Le Boisselier. (2015) Emerging drugs of abuse: current perspectives on synthetic cannabinoids. Substance Abuse and Rehabilitation 6, pages 113-129.
Read now
Read now
Joseph A. Tyndall, Roy Gerona, Giuliano De Portu, Jordan Trecki, Marie-Carmelle Elie, Judith Lucas, John Slish, Kenneth Rand, Lindsay Bazydlo, Martina Holder, Matthew F. Ryan, Paul Myers, Nicole Iovine, Michelle Plourde, Emily Weeks, James R. Hanley, Greg Endres, Danielle St. Germaine, Paul J. Dobrowolski & Michael Schwartz. (2015) An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA. Clinical Toxicology 53:10, pages 950-956.
Read now
Read now
Kathleen L. Egan, Cynthia K. Suerken, Beth A. Reboussin, John Spangler, Kimberly G. Wagoner, Erin L. Sutfin, Beata Debinski & Mark Wolfson. (2015) K2 and Spice use among a cohort of college students in southeast region of the USA. The American Journal of Drug and Alcohol Abuse 41:4, pages 317-322.
Read now
Read now
. (2015) XXXV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 26–29 May 2015, St Julian's, Malta. Clinical Toxicology 53:4, pages 233-403.
Read now
Read now
M. Takematsu, R. S. Hoffman, L. S. Nelson, J. M. Schechter, J. H. Moran & S. W. Wiener. (2014) A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid. Clinical Toxicology 52:9, pages 973-975.
Read now
Read now
G. L. Buser, R. R. Gerona, B. Z. Horowitz, K. P. Vian, M. L. Troxell, R. G. Hendrickson, D. C. Houghton, D. Rozansky, S. W. Su & R. F. Leman. (2014) Acute kidney injury associated with smoking synthetic cannabinoid. Clinical Toxicology 52:7, pages 664-673.
Read now
Read now
Andreja Celofiga, Jure Koprivsek & Janez Klavz. (2014) Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series. Journal of Dual Diagnosis 10:3, pages 168-173.
Read now
Read now
Y. Finkelstein, J. R. Hutson, S. B. Freedman, P. Wax & J. Brent. (2013) Drug-induced seizures in children and adolescents presenting for emergency care: Current and emerging trends. Clinical Toxicology 51:8, pages 761-766.
Read now
Read now
Articles from other publishers (143)
Hanan Hany Elrassas, Yasser Abdel Razek Elsayed, Mai SeifElDin Abdeen, Aya Taha Mohamed & Zeinab Mohamed El Nagar. (2023) Synthetic cannabinoids impact on cognitive functions. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 59:1.
Crossref
Crossref
Ryoichi Fujiwara, Megan Journey, Fatimah Al-Doori, Paris Bell, Brahmjot Judge, Kamille Miracle, Kousei Ito & Sabrina Jones. (2023) Potential neonatal toxicity of new psychoactive substances. Pharmacology & Therapeutics 248, pages 108468.
Crossref
Crossref
Mariana Campello de Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, Julio Torales, Antonio Ventriglio, Henrique Silva Bombana, Vilma Leyton, Cintia de Azevedo-Marques Périco, André Brooking Negrão, André Malbergier & João Maurício Castaldelli-Maia. (2023) Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review. Brain Sciences 13:7, pages 990.
Crossref
Crossref
Ngoc Tran, William E. Fantegrossi, Keith R. McCain, Xinwen Wang & Ryoichi Fujiwara. (2023) Identification of Cytochrome P450 Enzymes Responsible for Oxidative Metabolism of Synthetic Cannabinoid (1-Hexyl-1H-Indol-3-yl)-1-naphthalenyl-methanone (JWH-019). Catalysts 13:6, pages 1008.
Crossref
Crossref
Matteo Scopetti, Donato Morena, Federico Manetti, Alessandro Santurro, Nicola Di Fazio, Stefano D’Errico, Martina Padovano, Paola Frati & Vittorio Fineschi. (2023) Cannabinoids and Brain Damage: A Systematic Review on a Frequently
Overlooked Issue. Current Pharmaceutical Biotechnology 24:6, pages 741-757.
Crossref
Crossref
Arianna Giorgetti, Vasco Orazietti, Francesco Paolo Busardò & Raffaele Giorgetti. (2023) Psychomotor performances relevant for driving under the combined effect of ethanol and synthetic cannabinoids: A systematic review. Frontiers in Psychiatry 14.
Crossref
Crossref
Beatrice Marchetti, Sabrine Bilel, Micaela Tirri, Raffaella Arfè, Giorgia Corli, Elisa Roda, Carlo Alessandro Locatelli, Elena Cavarretta, Fabio De Giorgio & Matteo Marti. (2023) The Old and the New: Cardiovascular and Respiratory Alterations Induced by Acute JWH-018 Administration Compared to Δ9-THC—A Preclinical Study in Mice. International Journal of Molecular Sciences 24:2, pages 1631.
Crossref
Crossref
Thomas Gilson, David Dolinak, Susan F. Ely & James R. Gill. 2023. Principles of Forensic Pathology. Principles of Forensic Pathology
339
374
.
Kodi M. Endres, Krista Kierys, Yimeng Shang, Shouhao Zhou, Gary D. Ceneviva, Neal J. Thomas & Conrad Krawiec. (2022) A Multicenter Retrospective Evaluation of Specialized Laboratory Investigations in the Workup of Pediatric Patients With New-Onset Supraventricular Tachycardia. Journal of Emergency Nursing 48:6, pages 678-687.e1.
Crossref
Crossref
Liesl K. Janssens, Simon Hudson, David M. Wood, Caitlin Wolfe, Paul I. Dargan & Christophe P. Stove. (2022) Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites. Archives of Toxicology 96:11, pages 2935-2945.
Crossref
Crossref
Catheryn D. Wilson, Fang Zheng & William E. Fantegrossi. (2022) Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice. Psychopharmacology 239:10, pages 3237-3248.
Crossref
Crossref
Sara Malaca, Francesco P. Busardò, Giulio Nittari, Ascanio Sirignano & Giovanna Ricci. (2022) Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on
the Latest Insights. Current Pharmaceutical Design 28:32, pages 2603-2617.
Crossref
Crossref
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, Fabiano Reniero, Claude Guillou & Christophe P. Stove. (2022) Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists. Drug Testing and Analysis 14:9, pages 1565-1575.
Crossref
Crossref
Ana Y. Simão, Mónica Antunes, Emanuel Cabral, Patrik Oliveira, Luana M. Rosendo, Ana Teresa Brinca, Estefânia Alves, Hernâni Marques, Tiago Rosado, Luís A. Passarinha, Maristela Andraus, Mário Barroso & Eugenia Gallardo. (2022) An Update on the Implications of New Psychoactive Substances in Public Health. International Journal of Environmental Research and Public Health 19:8, pages 4869.
Crossref
Crossref
Eric Sparkes, Elizabeth A. Cairns, Richard C. Kevin, Felcia Lai, Katharina Elisabeth Grafinger, Shuli Chen, Marie H. Deventer, Ross Ellison, Rochelle Boyd, Lewis J. Martin, Iain S. McGregor, Roy R. Gerona, David E. Hibbs, Volker Auwärter, Michelle Glass, Christophe Stove & Samuel D. Banister. (2022)
Structure–activity relationships of valine,
tert
-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA
. RSC Medicinal Chemistry 13:2, pages 156-174.
Crossref
Crossref
Deborah Dal Farra, Alice Valdesalici, Giancarlo Zecchinato, Alfio De Sandre, Diego Saccon, Pierluigi Simonato, Ornella Corazza, Giovanni Martinotti, Andrew L. Smith & Marco Solmi. (2022) Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. International Journal of Environmental Research and Public Health 19:2, pages 915.
Crossref
Crossref
Martin F. Casey & Alex F. Manini. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
415
446
.
Iflah Hassan, Insha Mushtaq, Weekar Younus Raja & Zulfiqar Ali Bhat. 2022. Edible Plants in Health and Diseases. Edible Plants in Health and Diseases
205
248
.
Claude Cyr, Mellar P. Davis, Danial Schecter & Paul DaeninckMellar P. Davis. 2022. Cannabis and Cannabinoid-Based Medicines in Cancer Care. Cannabis and Cannabinoid-Based Medicines in Cancer Care
91
115
.
Vidyasagar Naik Bukke, Moola Archana, Rosanna Villani, Gaetano Serviddio & Tommaso Cassano. (2021) Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health. Pharmaceuticals 14:10, pages 965.
Crossref
Crossref
Yigit Sezer, Ayse Tarbin Jannuzzi, Marilyn A Huestis & Buket Alpertunga. (2020)
In vitro
assessment of the cytotoxic, genotoxic and oxidative stress effects of the synthetic cannabinoid JWH-018 in human SH-SY5Y neuronal cells
. Toxicology Research 9:6, pages 734-740.
Crossref
Crossref
Kenichi Tamama. 2021.
191
214
.
Masahiko Funada, Mika Takebayashi-Ohsawa & Ken-ich Tomiyama. (2020) Synthetic cannabinoids enhanced ethanol-induced motor impairments through reduction of central glutamate neurotransmission. Toxicology and Applied Pharmacology 408, pages 115283.
Crossref
Crossref
Derek Stitt & Neeraj Kumar. (2020) Drugs of Abuse and the Nervous System. CONTINUUM: Lifelong Learning in Neurology 26:3, pages 765-784.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Chris S. BreivogelJacob R. WellsAmreen JonasArtik H. MistryMorgan L. GravleyRajul M. PatelBrianna E. WhithornBonnie M. Brenseke. (2020)
Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ
9
-Tetrahydrocannabinol
. Cannabis and Cannabinoid Research 5:1, pages 32-41.
Crossref
Crossref
Kuhilan Gounder, Janavi Dunuwille, John Dunne, Judy Lee, Peter Silbert & Nicholas Lawn. (2020) The other side of the leaf: Seizures associated with synthetic cannabinoid use. Epilepsy & Behavior 104, pages 106901.
Crossref
Crossref
Sabrina Jones, Azure L. Yarbrough, William E. Fantegrossi, Paul L. Prather, John M. Bush, Anna Radominska‐Pandya & Ryoichi Fujiwara. (2020)
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid
N
‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1
H
‐indole‐3‐carboxamide (STS‐135)
. Pharmacology Research & Perspectives 8:1.
Crossref
Crossref
Hayriye Mihrimah Ozturk, Ertan Yetkin & Selcuk Ozturk. (2019) Synthetic Cannabinoids and Cardiac Arrhythmia Risk: Review of the Literature. Cardiovascular Toxicology 19:3, pages 191-197.
Crossref
Crossref
Catheryn D. Wilson, Sherrica Tai, Laura Ewing, Jasmine Crane, Taylor Lockhart, Ryochi Fujiwara, Anna Radominska-Pandya & William E. Fantegrossi. (2019) Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice. Journal of Pharmacology and Experimental Therapeutics 368:2, pages 146-156.
Crossref
Crossref
Laurent Karila & Amine Benyamina. 2019. Cannabis Use Disorders. Cannabis Use Disorders
169
176
.
Ziva D. Cooper & Arthur Robin Williams. 2019. Cannabis Use Disorders. Cannabis Use Disorders
103
111
.
Daryl BlaneyJr.Jr., Annise K. Jackson, Ozan Toy, Anna Fitzgerald & Joanna Piechniczek-Buczek. 2019. Substance Use and the Acute Psychiatric Patient. Substance Use and the Acute Psychiatric Patient
125
144
.
Emma Leishman, Michelle N. Murphy, Michelle I. Murphy, Ken Mackie & Heather B. Bradshaw. (2018) Broad and Region-Specific Impacts of the Synthetic Cannabinoid CP 55,940 in Adolescent and Adult Female Mouse Brains. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Alys H Hunter, T Ayres, N Moreland & A Cox. (2018) Phantom menace: novel psychoactive substances and the UK Armed Forces. Journal of the Royal Army Medical Corps 164:6, pages 450-457.
Crossref
Crossref
Samuel K. Cordeiro, Ryan C. Daro, Hyunuk Seung, Wendy Klein-Schwartz & Hong K. Kim. (2018) Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015. Addiction 113:10, pages 1850-1861.
Crossref
Crossref
Slavica Vučinić, Vesna Kilibarda, Snežana Đorđević, Dragana Đorđević, Nataša Perković-Vukčević, Gordana Vuković-Ercegović, Biljana Antonijević, Marijana Ćurčić, Evica Antonijević & Gordana Brajković. (2018) Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids. Archives of Industrial Hygiene and Toxicology 69:2, pages 178-185.
Crossref
Crossref
Amy L. Patton, Kathryn A. Seely, Azure L. Yarbrough, William Fantegrossi, Laura P. James, Keith R. McCain, Ryoichi Fujiwara, Paul L. Prather, Jeffery H. Moran & Anna Radominska-Pandya. (2018) Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants. Biochemical and Biophysical Research Communications 498:3, pages 597-602.
Crossref
Crossref
Kimberly S. Grant, Rebekah Petroff, Nina Isoherranen, Nephi Stella & Thomas M. Burbacher. (2018) Cannabis use during pregnancy: Pharmacokinetics and effects on child development. Pharmacology & Therapeutics 182, pages 133-151.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 2018. Rauschdrogen. Rauschdrogen
1
392
.
Olga Malyshevskaya, Kosuke Aritake, Mahesh K. Kaushik, Nahoko Uchiyama, Yoan Cherasse, Ruri Kikura-Hanajiri & Yoshihiro Urade. (2017) Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor. Scientific Reports 7:1.
Crossref
Crossref
Pedro Miguel dos Santos Oliveira, Ana Sofia Félix Morais & Nuno Gonçalo Gomes Fernandes Madeira. (2017) Synthetic Cannabis Analogues and Suicidal Behavior: Case Report. Journal of Addiction Medicine 11:5, pages 408-410.
Crossref
Crossref
Lenka Hruba & Lance R. McMahon. (2017) Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics 362:2, pages 278-286.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Francois R. Lamy, Raminta Daniulaityte, Ramzi W. Nahhas, Monica J. Barratt, Alan G. Smith, Amit Sheth, Silvia S. Martins, Edward W. Boyer & Robert G. Carlson. (2017) Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis. International Journal of Drug Policy 44, pages 121-129.
Crossref
Crossref
Rose Cairns, Jared A. Brown, Naren Gunja & Nicholas A. Buckley. (2017) The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre. International Journal of Drug Policy 43, pages 74-82.
Crossref
Crossref
Isabella Canazza, Andrea Ossato, Fabrizio Vincenzi, Adolfo Gregori, Fabiana Di Rosa, Federica Nigro, Alessandro Rimessi, Paolo Pinton, Katia Varani, Pier Andrea Borea & Matteo Marti. (2017) Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies. Human Psychopharmacology: Clinical and Experimental 32:3, pages e2601.
Crossref
Crossref
Brian F. Thomas, Timothy W. Lefever, Ricardo A. Cortes, Megan Grabenauer, Alexander L. Kovach, Anderson O. Cox, Purvi R. Patel, Gerald T. Pollard, Julie A. Marusich, Richard C. Kevin, Thomas F. Gamage & Jenny L. Wiley. (2017) Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences. Journal of Pharmacology and Experimental Therapeutics 361:1, pages 162-171.
Crossref
Crossref
Benjamin M. Ford, Sherrica Tai, William E. Fantegrossi & Paul L. Prather. (2017) Synthetic Pot: Not Your Grandfather’s Marijuana. Trends in Pharmacological Sciences 38:3, pages 257-276.
Crossref
Crossref
Neil A. Patel, Jason M. Jerry, Xavier F. Jimenez & Stephen T. Hantus. (2017) New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic Cannabinoids. Psychosomatics 58:2, pages 180-186.
Crossref
Crossref
Amandine Scocard, Amine Benyamina, Sarah Coscas & Laurent Karila. (2017) Cannabinoïdes de synthèse : une nouvelle matrice des addictions. La Presse Médicale 46:1, pages 11-22.
Crossref
Crossref
Colin Davidson, Jolanta Opacka-Juffry, Angel Arevalo-Martin, Daniel Garcia-Ovejero, Eduardo Molina-Holgado & Francisco Molina-Holgado. 2017. Cannabinoid Pharmacology. Cannabinoid Pharmacology
135
168
.
Paul R. Smith & Stephen R. Morley. 2017. Essentials of Autopsy Practice. Essentials of Autopsy Practice
59
85
.
Philippe E. Hantson. 2017. Critical Care Toxicology. Critical Care Toxicology
447
473
.
Sajjad Ahmad, Farhat Ullah, Muhammad Ayaz, Anwar Zeb, Farman Ullah & Abdul Sadiq. (2016) Antitumor and anti-angiogenic potentials of isolated crude saponins and various fractions of Rumex hastatus D. Don.. Biological Research 49:1.
Crossref
Crossref
Joseph B. Richardson, Christopher St. Vil, Eric Wish & Carnell Cooper. (2016) “On papers”: perceptions of synthetic cannabinoid use among black males under criminal justice supervision. Health & Justice 4:1.
Crossref
Crossref
Milana Zaurova, Robert S. Hoffman, David Vlahov & Alex F. Manini. (2016) Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose. Journal of Medical Toxicology 12:4, pages 335-340.
Crossref
Crossref
Austin Adair, Spencer C. Greene, Christopher S. Greeley, Ryan D. Coleman & Lara S. Shekerdemian. (2016) Synthetic Cannabinoid Exposure. Clinical Pediatrics 55:11, pages 1075-1077.
Crossref
Crossref
Laura Mercolini & Michele Protti. (2016) Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis. Journal of Pharmaceutical and Biomedical Analysis 130, pages 202-219.
Crossref
Crossref
Isabella Canazza, Andrea Ossato, Claudio Trapella, Anna Fantinati, Maria Antonietta De Luca, Giulia Margiani, Fabrizio Vincenzi, Claudia Rimondo, Fabiana Di Rosa, Adolfo Gregori, Katia Varani, Pier Andrea Borea, Giovanni Serpelloni & Matteo Marti. (2016) Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on ?tetrad?, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Psychopharmacology 233:21-22, pages 3685-3709.
Crossref
Crossref
Maren Hermanns-Clausen, Josephine Kithinji, Marco Spehl, Verena Angerer, Florian Franz, Florian Eyer & Volker Auwärter. (2016) Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project. Drug Testing and Analysis 8:10, pages 1030-1038.
Crossref
Crossref
Andreas Carlsson, Sandra Lindberg, Xiongyu Wu, Simon Dunne, Martin Josefsson, Crister Åstot & Johan Dahlén. (2016)
Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1
H
-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1
H
-indol-3-yl(adamantan-1-yl)methanone
. Drug Testing and Analysis 8:10, pages 1015-1029.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2016. Current Practice in Forensic Medicine. Current Practice in Forensic Medicine
35
46
.
Ziva D. Cooper. (2016) Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. Current Psychiatry Reports 18:5.
Crossref
Crossref
Kevin G. Shanks, William Clark & George Behonick. (2016) Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA. Journal of Analytical Toxicology 40:3, pages 236-239.
Crossref
Crossref
Liana Fattore. (2016) Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Biological Psychiatry 79:7, pages 539-548.
Crossref
Crossref
Daniel Castellanos. (2016) Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. World Journal of Clinical Pediatrics 5:1, pages 16.
Crossref
Crossref
Patrycja Kleczkowska, Irena Smaga, Małgorzata Filip & Magdalena Bujalska-Zadrozny. (2015) Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?. Neurotoxicity Research 29:1, pages 173-196.
Crossref
Crossref
Sherrica Tai & William E. Fantegrossi. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
249
262
.
Jenny L. Wiley, Julie A. Marusich & Brian F. Thomas. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
231
248
.
Sara Andrabi, Spencer Greene, Nidal Moukaddam & Benjamin Li. (2015) New Drugs of Abuse and Withdrawal Syndromes. Emergency Medicine Clinics of North America 33:4, pages 779-795.
Crossref
Crossref
Steven Karch & Olaf Drummer. 2015. Karch's Pathology of Drug Abuse, Fifth Edition. Karch's Pathology of Drug Abuse, Fifth Edition
805
832
.
Evan C. Rosenberg, Richard W. Tsien, Benjamin J. Whalley & Orrin Devinsky. (2015) Cannabinoids and Epilepsy. Neurotherapeutics 12:4, pages 747-768.
Crossref
Crossref
C. Lovett, D. M. Wood & P. I. Dargan. (2015) Pharmacology and toxicology of the synthetic cannabinoid receptor agonistsPharmacologie et toxicologie des agonistes synthétiques des récepteurs cannabinoïdes. Réanimation 24:5, pages 527-541.
Crossref
Crossref
A. Ossato, A. Vigolo, C. Trapella, C. Seri, C. Rimondo, G. Serpelloni & M. Marti. (2015) JWH-018 impairs sensorimotor functions in mice. Neuroscience 300, pages 174-188.
Crossref
Crossref
A. Vigolo, A. Ossato, C. Trapella, F. Vincenzi, C. Rimondo, C. Seri, K. Varani, G. Serpelloni & M. Marti. (2015) Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice. Neuropharmacology 95, pages 68-82.
Crossref
Crossref
Samuel D. Banister, Jordyn Stuart, Trent Conroy, Mitchell Longworth, Madhura Manohar, Corinne Beinat, Shane M. Wilkinson, Richard C. Kevin, David E. Hibbs, Michelle Glass, Mark Connor, Iain S. McGregor & Michael Kassiou. (2015) Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues. Forensic Toxicology 33:2, pages 355-366.
Crossref
Crossref
Mariko Tominaga, Tomomi Michiue, Osamu Inamori-Kawamoto, Asmaa Mohammed Hishmat, Shigeki Oritani, Masashi Takama, Takaki Ishikawa & Hitoshi Maeda. (2015) Efficacy of drug screening in forensic autopsy: Retrospective investigation of routine toxicological findings. Legal Medicine 17:3, pages 172-176.
Crossref
Crossref
Michael D. Schwartz, Jordan Trecki, Laura A. Edison, Alaina R. Steck, Justin K. Arnold & Roy R. Gerona. (2015) A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA. The Journal of Emergency Medicine 48:5, pages 573-580.
Crossref
Crossref
Joanna Znaleziona, Pavlína Ginterová, Jan Petr, Peter Ondra, Ivo Válka, Juraj Ševčík, Jan Chrastina & Vítězslav Maier. (2015) Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques – a review. Analytica Chimica Acta 874, pages 11-25.
Crossref
Crossref
Stephanie A. Dean, Rebecca Jufer-Phipps, David R. Fowler, Robert Kutys, Elena Ladich & Russell Alexander. (2015) Acute Coronary Artery Thrombosis Associated with Synthetic Cannabinoid Intoxication. Academic Forensic Pathology 5:1, pages 127-132.
Crossref
Crossref
Jan van Amsterdam, Tibor Brunt & Wim van den Brink. (2015) The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. Journal of Psychopharmacology 29:3, pages 254-263.
Crossref
Crossref
Anne-Laure Pélissier-Alicot. (2015) Les cannabinoïdes de synthèse : épidémiologie, modalités de consommations et effets cliniques. Toxicologie Analytique et Clinique 27:1, pages 33-40.
Crossref
Crossref
Brian P. Kersten & Megan E. McLaughlin. (2014) Toxicology and Management of Novel Psychoactive Drugs. Journal of Pharmacy Practice 28:1, pages 50-65.
Crossref
Crossref
R. Geryk, M. Švidrnoch, A. Přibylka, K. Kalíková, V. Maier & E. Tesařová. (2015) A supercritical fluid chromatography method for the systematic toxicology analysis of cannabinoids and their metabolites. Analytical Methods 7:15, pages 6056-6059.
Crossref
Crossref
Ritva Karinen, Silja Skogstad Tuv, Elisabeth Leere Øiestad & Vigdis Vindenes. (2015) Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids. Forensic Science International 246, pages 98-103.
Crossref
Crossref
Alberto Salomone. 2015. Hair Analysis in Clinical and Forensic Toxicology. Hair Analysis in Clinical and Forensic Toxicology
301
336
.
Magdy A. Kharoshah, Mohammed Saleh Madadin, Sherien Salah Ghaleb, Hanan Hosny Hassan, Kholoud Samy Alsowayigh & Ritesh George Menezes. 2015. Heart and Toxins. Heart and Toxins
571
594
.
Philippe E. Hantson. 2016. Critical Care Toxicology. Critical Care Toxicology
1
27
.
Davide Lonati, Eleonora Buscaglia, Pietro Papa, Antonella Valli, Teresa Coccini, Andrea Giampreti, Valeria Margherita Petrolini, Sarah Vecchio, Giovanni Serpelloni & Carlo Alessandro Locatelli. (2014) MAM-2201 (Analytically Confirmed) Intoxication After ?Synthacaine? Consumption. Annals of Emergency Medicine 64:6, pages 629-632.
Crossref
Crossref
Marisol S. Castaneto, David A. Gorelick, Nathalie A. Desrosiers, Rebecca L. Hartman, Sandrine Pirard & Marilyn A. Huestis. (2014) Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence 144, pages 12-41.
Crossref
Crossref
A Pourmand, P Armstrong, M Mazer-Amirshahi & H Shokoohi. (2014) The evolving high. Human & Experimental Toxicology 33:10, pages 993-999.
Crossref
Crossref
George Behonick, Kevin G. Shanks, Dennis J. Firchau, Gagan Mathur, Charles F. Lynch, Marcus Nashelsky, David J. Jaskierny & Chady Meroueh. (2014) Four Postmortem Case Reports with Quantitative Detection of the Synthetic Cannabinoid, 5F-PB-22. Journal of Analytical Toxicology 38:8, pages 559-562.
Crossref
Crossref
M. Sa?aga, A. Mokrowiecka, P.K. Zakrzewski, A. Cygankiewicz, E. Leishman, M. Sobczak, H. Zatorski, E. Ma?ecka-Panas, R. Kordek, M. Storr, W.M. Krajewska, H.B. Bradshaw & J. Fichna. (2014) Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH). Journal of Crohn's and Colitis 8:9, pages 998-1009.
Crossref
Crossref
Luca Zamengo, Giampietro Frison, Chiara Bettin & Rocco Sciarrone. (2014) Understanding the risks associated with the use of new psychoactive substances (NPS): High variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products. Toxicology Letters 229:1, pages 220-228.
Crossref
Crossref
Luke Yip & Richard C. Dart. (2014) Is there something more about synthetic cannabinoids?. Forensic Toxicology 32:2, pages 340-341.
Crossref
Crossref
Randy L. Luciano & Mark A. Perazella. (2014) Nephrotoxic effects of designer drugs: synthetic is not better!. Nature Reviews Nephrology 10:6, pages 314-324.
Crossref
Crossref
Albert A. Elian & Jeffery Hackett. (2014) Analysis of AM-2201 and metabolites in a drugs and driving case. Drug Testing and Analysis 6:4, pages 389-395.
Crossref
Crossref
Jolanta B. Zawilska & Jakub Wojcieszak. (2013) Spice/K2 drugs ? more than innocent substitutes for marijuana. The International Journal of Neuropsychopharmacology 17:03, pages 509-525.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging drugs of abuse. Disease-a-Month 60:3, pages 110-132.
Crossref
Crossref
William E. Fantegrossi, Jeffery H. Moran, Anna Radominska-Pandya & Paul L. Prather. (2014) Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to ?9-THC: Mechanism underlying greater toxicity?. Life Sciences 97:1, pages 45-54.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging Drugs of Abuse. Emergency Medicine Clinics of North America 32:1, pages 1-28.
Crossref
Crossref
Laura M. Huppertz, Stefan Kneisel, Volker Auwärter & Jürgen Kempf. (2014) A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization. Journal of Mass Spectrometry 49:2, pages 117-127.
Crossref
Crossref
Saif Ibrahim, Farah Al-Saffar & Thomas Wannenburg. (2014) A Unique Case of Cardiac Arrest following K2 Abuse. Case Reports in Cardiology 2014, pages 1-3.
Crossref
Crossref
Joel Schlatter. 2014.
291
311
.
Rajiv Radhakrishnan, Peter H. Addy, R. Andrew Sewell, Patrick D. Skosnik, Mohini Ranganathan & Deepak Cyril D’Souza. 2014. The Effects of Drug Abuse on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System
423
474
.
Amitava Dasgupta & Amer Wahed. 2014. Clinical Chemistry, Immunology and Laboratory Quality Control. Clinical Chemistry, Immunology and Laboratory Quality Control
307
316
.
J.M. Marraffa. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
248
251
.
Andrew T. Kicman & Leslie A. King. (2014) The current situation with cannabinoids. Drug Testing and Analysis 6:1-2, pages 1-6.
Crossref
Crossref
Kathryn A. Seely, Amy L. Patton, Cindy L. Moran, Mary L. Womack, Paul L. Prather, William E. Fantegrossi, Anna Radominska-Pandya, Gregory W. Endres, Kermit B. Channell, Nathaniel H. Smith, Keith R. McCain, Laura P. James & Jeffery H. Moran. (2013) Forensic investigation of K2, Spice, and ?bath salt? commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Science International 233:1-3, pages 416-422.
Crossref
Crossref
Jihyun Kim, Sanghwan In, Yuran Park, Meejung Park, Eunmi Kim & Sooyeun Lee. (2013) Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation. Analytical and Bioanalytical Chemistry 405:30, pages 9769-9778.
Crossref
Crossref
Amy L. Patton, Krishna C. Chimalakonda, Cindy L. Moran, Keith R. McCain, Anna Radominska-Pandya, Laura P. James, Charles Kokes & Jeffery H. Moran. (2013) K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure. Journal of Forensic Sciences 58:6, pages 1676-1680.
Crossref
Crossref
R. Kronstrand, M. Roman, M. Andersson & A. Eklund. (2013) Toxicological Findings of Synthetic Cannabinoids in Recreational Users. Journal of Analytical Toxicology 37:8, pages 534-541.
Crossref
Crossref
J. K. Yeakel & B. K. Logan. (2013) Blood Synthetic Cannabinoid Concentrations in Cases of Suspected Impaired Driving. Journal of Analytical Toxicology 37:8, pages 547-551.
Crossref
Crossref
Amy L. Patton, Kathryn A. Seely, Krishna C. Chimalakonda, Johnny P. Tran, Matthew Trass, Art Miranda, William E. Fantegrossi, Paul D. Kennedy, Paul Dobrowolski, Anna Radominska-Pandya, Keith R. McCain, Laura P. James, Gregory W. Endres & Jeffery H. Moran. (2013) Targeted Metabolomic Approach for Assessing Human Synthetic Cannabinoid Exposure and Pharmacology. Analytical Chemistry 85:19, pages 9390-9399.
Crossref
Crossref
Fermin BarruetoJr.Jr., Rajender Gattu & Maryann Mazer-Amirshahi. (2013) Updates in the General Approach to the Pediatric Poisoned Patient. Pediatric Clinics of North America 60:5, pages 1203-1220.
Crossref
Crossref
Burton W. WilckeJr.Jr., Sadira Y. Del Rio Daher & Karen J. Breckenridge. (2013) Supporting Public Health Laboratory Systems Research. Public Health Reports 128:2_suppl, pages 10-13.
Crossref
Crossref
Maren Hermanns-Clausen, Stefan Kneisel, Melanie Hutter, Bela Szabo & Volker Auwärter. (2013) Acute intoxication by synthetic cannabinoids - Four case reports. Drug Testing and Analysis 5:9-10, pages 790-794.
Crossref
Crossref
Max Spaderna, Peter H. Addy & Deepak Cyril D’Souza. (2013) Spicing things up: synthetic cannabinoids. Psychopharmacology 228:4, pages 525-540.
Crossref
Crossref
Samuel D. Banister, Shane M. Wilkinson, Mitchell Longworth, Jordyn Stuart, Nadine Apetz, Katrina English, Lance Brooker, Catrin Goebel, David E. Hibbs, Michelle Glass, Mark Connor, Iain S. McGregor & Michael Kassiou. (2013) The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse. ACS Chemical Neuroscience 4:7, pages 1081-1092.
Crossref
Crossref
Nicholas Nacca, Deepak Vatti, Ross Sullivan, Payal Sud, Mark Su & Jeanna Marraffa. (2013) The Synthetic Cannabinoid Withdrawal Syndrome. Journal of Addiction Medicine 7:4, pages 296-298.
Crossref
Crossref
Melanie Hutter, Bjoern Moosmann, Stefan Kneisel & Volker Auwärter. (2013) Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM‐2201 regarding its chemistry and metabolism. Journal of Mass Spectrometry 48:7, pages 885-894.
Crossref
Crossref
A. Arntson, B. Ofsa, D. Lancaster, J. R. Simon, M. McMullin & B. Logan. (2013) Validation of a Novel Immunoassay for the Detection of Synthetic Cannabinoids and Metabolites in Urine Specimens. Journal of Analytical Toxicology 37:5, pages 284-290.
Crossref
Crossref
Wilson Z. Ray, Khaled M. Krisht, Alex Schabel & Richard H. Schmidt. (2012) Subarachnoid Hemorrhage from a Thoracic Radicular Artery Pseudoaneurysm after Methamphetamine and Synthetic Cannabinoid Abuse: Case Report. Global Spine Journal 3:2, pages 119-123.
Crossref
Crossref
Stefan Kneisel, Michael Speck, Bjoern Moosmann, Todd M. Corneillie, Nathaniel G. Butlin & Volker Auwärter. (2013) LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows. Analytical and Bioanalytical Chemistry 405:14, pages 4691-4706.
Crossref
Crossref
Hyeyoung Choi, Sewoong Heo, Sanggil Choe, Wonkyung Yang, Yuran Park, Eunmi Kim, Heesun Chung & Jaesin Lee. (2012) Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS. Analytical and Bioanalytical Chemistry 405:12, pages 3937-3944.
Crossref
Crossref
Donata Favretto, Jennifer P. Pascali & Franco Tagliaro. (2013) New challenges and innovation in forensic toxicology: Focus on the “New Psychoactive Substances”. Journal of Chromatography A 1287, pages 84-95.
Crossref
Crossref
Maren Hermanns‐Clausen, Stefan Kneisel, Bela Szabo & Volker Auwärter. (2012) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 108:3, pages 534-544.
Crossref
Crossref
David McQuade, Simon Hudson, Paul I. Dargan & David M. Wood. (2012) First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. European Journal of Clinical Pharmacology 69:3, pages 373-376.
Crossref
Crossref
Volker Auwärter, Paul I. Dargan & David M. Wood. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
317
343
.
Hyeyoung Choi, Sewoong Heo, Eunmi Kim, Bang Yeon Hwang, Chul Lee & Jaesin Lee. (2012) Identification of (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone and its 5-pentyl fluorinated analog in herbal incense seized for drug trafficking. Forensic Toxicology 31:1, pages 86-92.
Crossref
Crossref
Adrian Derungs, Andrea E. Schwaninger, Gregory Mansella, Roland Bingisser, Thomas Kraemer & Matthias E. Liechti. (2012) Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201. Forensic Toxicology 31:1, pages 164-171.
Crossref
Crossref
Laura M. TormoehlenNeeraj Kumar. (2012) Neurotoxicology. Neurology Clinical Practice 2:4, pages 301-310.
Crossref
Crossref
Felecia N. JinwalaMayank Gupta. (2012) Synthetic Cannabis and Respiratory Depression. Journal of Child and Adolescent Psychopharmacology 22:6, pages 459-462.
Crossref
Crossref
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran & Liana Fattore. (2012) Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 234-243.
Crossref
Crossref
Jason M. Wiebelhaus, Justin L. Poklis, Alphonse Poklis, Robert E. Vann, Aron H. Lichtman & Laura E. Wise. (2012) Inhalation exposure to smoke from synthetic ?marijuana? produces potent cannabimimetic effects in mice. Drug and Alcohol Dependence 126:3, pages 316-323.
Crossref
Crossref
Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton, Lisa K. Brents, Cindy L. Moran, Gregory W. Endres, Laura P. James, Paul F. Hollenberg, Paul L. Prather, Anna Radominska-Pandya & Jeffery H. Moran. (2012) Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands. Drug Metabolism and Disposition 40:11, pages 2174-2184.
Crossref
Crossref
Babak Tofighi & Joshua D. Lee. (2012) Internet Highs—Seizures After Consumption of Synthetic Cannabinoids Purchased Online. Journal of Addiction Medicine 6:3, pages 240-241.
Crossref
Crossref
David M. Wood & Paul I. Dargan. (2012) Novel Psychoactive Substances. Therapeutic Drug Monitoring 34:4, pages 363-367.
Crossref
Crossref
Sadip Pant, Bhagirath Dholaria, Varinder Kaur, Samayuktha Ramavaram, Mary Ukor, Abhishek Deshmukh & Gerson A. Teran. (2012) Spicy Seizure. The American Journal of the Medical Sciences 344:1, pages 67-68.
Crossref
Crossref
Robert Stoppacher. (2012) Synthetic Cannabinoid Use and Sudden Death. Academic Forensic Pathology 2:2, pages 202-205.
Crossref
Crossref
Christopher D. Rosenbaum, Stephanie P. Carreiro & Kavita M. Babu. (2012) Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines. Journal of Medical Toxicology 8:1, pages 15-32.
Crossref
Crossref
Silja Skogstad Tuv, Maren Cecilie Strand, Ritva Karinen, Elisabeth Leere Øiestad, Asbjørg S. Christophersen & Vigdis Vindenes. (2012) Syntetiske cannabinoider - effekt og forekomst. Tidsskrift for Den norske legeforening 132:20, pages 2285-2288.
Crossref
Crossref